Proviva Therapeutics
About:
Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.
Top Investors: Viva BioInnovator, JMCR Partners, Viva Ventures Biotech Fund, Sangel Capital, Longpan Investment
Description:
Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins. It is committed to solving the problem of drug metabolism and the delivery of cytogenic drugs.
Total Funding Amount:
$18M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2019-01-01
Founders:
Number of Employees:
Last Funding Date:
2024-03-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai